These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10721275)

  • 1. [Children and adolescents with mental disorders as orphans of managed care?].
    Fegert JM; Rothärmel S
    Prax Kinderpsychol Kinderpsychiatr; 2000 Feb; 49(2):127-32. PubMed ID: 10721275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescription of drugs without registered indication].
    Wetterling T
    Fortschr Neurol Psychiatr; 2004 May; 72(5):245-54. PubMed ID: 15136945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Legal decisions of german supreme courts about prescription of drugs for not registered indications ("off-label-use")].
    Wetterling T
    Fortschr Neurol Psychiatr; 2004 May; 72(5):255-9. PubMed ID: 15136946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Off-label use in psychiatry].
    Weih M; Thürauf N; Bleich S; Kornhuber J
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):7-13. PubMed ID: 17899492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Off-label use of drugs in psychiatry and neurology].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2004 May; 72(5):243-4. PubMed ID: 15136944
    [No Abstract]   [Full Text] [Related]  

  • 7. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A one-day survey of characteristics of off-label hospital prescription of psychotropic drugs.
    Martin-Latry K; Ricard C; Verdoux H
    Pharmacopsychiatry; 2007 May; 40(3):116-20. PubMed ID: 17541887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in mental health cost growth: an expanded role for management?
    Frank RG; Goldman HH; McGuire TG
    Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
    Harder Yv
    Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
    Harpaz-Rotem I; Rosenheck RA
    Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Off-label applications (professional rationales, financial possibilities)].
    László P
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):111-2. PubMed ID: 18399028
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
    Fritze J
    Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
    [No Abstract]   [Full Text] [Related]  

  • 14. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
    Fritze J
    Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence].
    Hebebrand J; Gerlach M
    Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):280-2. PubMed ID: 20306786
    [No Abstract]   [Full Text] [Related]  

  • 16. [Limited prescribing freedom by federal cost regulation?].
    Lasek R
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):633-5. PubMed ID: 9527458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.
    Zuvekas SH
    Health Aff (Millwood); 2005; 24(1):195-205. PubMed ID: 15647230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of the 12th and 14th amendments to the AMG (Medical Preparations Act) on paediatric pharmaceutical research--a survey of the new regulations].
    Kölch M; Lippert HD; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2006 Mar; 34(2):117-26. PubMed ID: 16610597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prerequisites in prescribing practice: physician decision processes].
    Dierks C
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):620-4. PubMed ID: 9527454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparing individual costs for treatment in acute day and inpatient care--results from a randomised controlled trial].
    Kallert TW; Schönherr R; Fröhling D; Schützwohl M
    Psychiatr Prax; 2007 Nov; 34(8):377-83. PubMed ID: 17671918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.